Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Cardiovasc Transl Res. 2015 May 7;8(5):283–292. doi: 10.1007/s12265-015-9629-1

Figure 3a.

Figure 3a

Comparison of the change from baseline to three months in weight (kg), BMI (kg/m2), systolic blood pressure (mmHg), exercise capacity (ml O2/kg/min), diet scores, and Dartmouth QOL scores in those using the PHA during CR and those undergoing usual CR. Significant reductions in weight (−4.0±0.9 kg, p=0.03), systolic blood pressure (−10.8±6.1, p=0.01), and QOL (−5.6±3.9, p=0.009) were observed in those patients utilizing the PHA concomitantly with standard Mayo Clinic CR.